---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-098661"
form_type: "8-K"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2023-12-26T23:59:59+00:00"
generated_at: "2026-06-07T07:24:51.187355+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aditxt exchanges Evofem Preferred for Series A-1 Conv. Preferred, regains Nasdaq compliance

## Summary
- Exchanged 22,280 shares of Evofem Series F-1 Preferred for same number of Aditxt Series A-1 Preferred (stated value $1,000 each).
- Series A-1 Preferred convertible at initial price $4.44; alternate conversion price floored at $0.888, includes 4.99% beneficial ownership cap.
- Filed Certificate of Designations for Series A-1 Convertible Preferred with Delaware Secretary of State.
- Believes it regained compliance with Nasdaq's $2.5M stockholders' equity requirement; awaits confirmation.
- Registration Rights Agreement requires filing Form S-3 for resale of conversion shares; failure triggers 2% monthly penalty.

## SEC filing metadata
- accession: 0001213900-23-098661
- form_type: 8-K
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2023-12-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390023098661/0001213900-23-098661-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390023098661/ea190663-8k_aditxtinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-098661
- JSON: https://secwatch.observer/filing/0001213900-23-098661.json
- Plain text: https://secwatch.observer/filing/0001213900-23-098661.txt

## Key facts
- Governance Changes
  Aditxt, Inc.: Filed Certificate of Designation for Series A-1 Convertible Preferred Stock with the Delaware Secretary of State (effective 2023-12-22).
  - Change: charter amendment
  - Effective: 2023-12-22
  source text: On December 22, 2023, the Company filed a Certificate of Designation for its Series A-1 Preferred Stock with the Secretary of State of Delaware (the “ Series A-1 Certificate of Designations ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390023098661/0001213900-23-098661-index.htm
- Material Agreements
  Aditxt, Inc. entered into Registration Rights Agreement with Holders of Evofem Series F-1 Convertible Preferred Stock valued at Registration Rights Agreement covering resale of Conversion Shares (effective 2023-12-26).
  - Action: entry
  - Counterparty: Holders of Evofem Series F-1 Convertible Preferred Stock
  - Value: Registration Rights Agreement covering resale of Conversion Shares
  - Effective: 2023-12-26
  source text: On December 26, 2023, in connection with the Exchange Agreement, the Company entered into a Registration Rights Agreement with the Holders (the “ Registration Rights Agreement ”), pursuant to which the Company agreed to prepare and file with the Securities and Exchange Commission (the “ SEC ”) a registration statement on Form S-3 (the “ Registration Statement ”) covering the resale of the shares of the Company’s common stock, par value $0.001 (the “ Common Stock ”) issuable upon conversion of the Series A-1 Preferred Stock (the “ Conversion Shares ”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390023098661/0001213900-23-098661-index.htm
- Material Agreements
  Aditxt, Inc. entered into Exchange Agreement with holders of Evofem Series F-1 Convertible Preferred Stock valued at Exchange of 22,280 shares of Evofem Series F-1 Preferred Stock for 22,280 shares of Company Series A (effective 2023-12-22).
  - Action: entry
  - Counterparty: holders of Evofem Series F-1 Convertible Preferred Stock
  - Value: Exchange of 22,280 shares of Evofem Series F-1 Preferred Stock for 22,280 shares of Company Series A
  - Effective: 2023-12-22
  source text: on December 22, 2023, the Company entered into an Exchange Agreement (the “ Exchange Agreement ”) with the holders (the “ Holders ”) of an aggregate of 22,280 shares of Series F-1 Convertible Preferred Stock of Evofem (the “ Evofem Series F-1 Preferred Stock ”) agreed to exchange their respective shares of Evofem Series F-1 Preferred Stock for an aggregate of 22,280 shares of a new series of convertible preferred stock of the Company designated as Series A-1 Convertible Preferred Stock, $0.001 par value, (the “ Series A-1 Preferred Stock ”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390023098661/0001213900-23-098661-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.